Drugs Controller General Of India Has Given Bharat Biotech Covaxin Emergency Use Approval For 12-18 Year Olds

https://economictimes.indiatimes.com/news/india/bharat-biotechs-covid-19-vaccine-for-kids-gets-dcgi-nod-for-emergency-use/videoshow/88495174.cms

byCharles Gross

December 25, 2021

1 minute read

https://economictimes.indiatimes.com/news/india/bharat-biotechs-covid-19-vaccine-for-kids-gets-dcgi-nod-for-emergency-use/videoshow/88495174.cms

AzurRx BioPharma Announces Phase 2 MS1819 Combination Therapy Trial Met Primary And Secondary Outcome Measure Endpoints

By Bill Haddad

August 18, 7:13 AM

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpoints Study data indicates clinically meaningful improvement in coefficient of fat MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpoints

AZRX

Target Unveils 2023 Strategic Investments To Fuel Growth And A Differentiated Guest Experience

By Happy Mohamed

February 28, 2:04 PM

Retailer to deliver 'affordable joy' through an unparalleled assortment of owned brands and a renewed focus on deal-conscious shoppers Drive Up Returns rolling

TGT

Teledyne FLIR Defense Teams With MFE Inspection Solutions To Integrate MUVE C360 Chemical Hazard Sensor On Drones And Boston Dynamics’ Spot Robot

By Benzinga Newsdesk

April 7, 8:27 AM

Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced that it has teamed with MFE Inspection Solutions to integrate the FLIR MUVE™ C360 multi-gas detector on Boston

TDY

Telsey Advisory Says Costco Is ‘Executing Well’; Sees Notable Upside

By Shivani Kumaresan

July 8, 12:29 PM

Telsey Advisory Group analyst Joseph Feldman reiterated its Outperform rating on Costco Wholesale Corp (NASDAQ:COST) shares with a price target of $590 (17%…

COST

Drugs Controller General Of India Has Given Bharat Biotech Covaxin Emergency Use Approval For 12-18 Year Olds

Related Posts

AzurRx BioPharma Announces Phase 2 MS1819 Combination Therapy Trial Met Primary And Secondary Outcome Measure Endpoints

Target Unveils 2023 Strategic Investments To Fuel Growth And A Differentiated Guest Experience

Teledyne FLIR Defense Teams With MFE Inspection Solutions To Integrate MUVE C360 Chemical Hazard Sensor On Drones And Boston Dynamics’ Spot Robot

Telsey Advisory Says Costco Is ‘Executing Well’; Sees Notable Upside